Actinic Keratosis: The Key Event in the Evolution from Photoaged Skin to Squamous Cell Carcinoma - Therapy Based on Pathogenetic and Clinical Aspects

Skin Pharmacology and Physiology

Volumn 17, Issue 2, 2004, Pages 67-76

  Oppel, T ^a,b   Korting, H C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Actinic keratosis; Diclofenac; Heliodermatitis; Photoaging; T4 endonuclease V

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; HUMAN; KERATOSIS; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; SUN; ULTRAVIOLET RADIATION;

CARCINOMA, SQUAMOUS CELL; HUMANS; KERATOSIS; SKIN AGING; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 1342280468     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076016     Document Type: Article

References (91)

1. Thompson SC, Jolley D, Marks R: Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993;329:1147-1151.
2. Berneburg M, Plettenberg H, Krutmann J: Photoaging of human skin. Photodermatol Photoimmunol Photomed 2000;16:239-244.
3. Wlaschek M, Tantcheva-Poor I, Naderi L, Ma W, Schneider LA, Razi-Wolf Z, Schuller J, Scharffetter-Kochanek K: Solar UV irradiation and dermal photoaging. J Photochem Photobiol B 2001;63:41-51.
4. Goldberg LH, Altman A: Benign skin changes associated with chronic sunlight exposure. Cutis 1984;34:33-38, 40.
5. Kligman AM, Kligman LH: Photoaging; in Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds): Fitzpatrick's Dermatology in General Medicine. New York, McGraw-Hill, 1999, pp 1717-1721.
6. Lavker RM, Kligman AM: Chronic heliodermatitis: A morphologic evaluation of chronic actinic dermal damage with emphasis on the role of mast cells. J Invest Dermatol 1988;90:325-330.
7. Berhane T, Halliday GM, Cooke B, Barnetson RS: Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol 2002;146:810-815.
8. Bart RS: Dermatoheliosis? J Am Acad Dermatol 1996;35:649-650.
9. Berneburg M, Gattermann N, Stege H, Grewe M, Vogelsang K, Ruzicka T, Krutmann J: Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic system. Photochem Photobiol 1997;66:271-275.
10. Birch-Machin MA, Tindall M, Turner R, Haldane F, Rees JL: Mitochondrial DNA deletions in human skin reflect photo rather than chronologic aging. J Invest Dermatol 1998;110:149-152.
11. Wei YH: Mitochondrial DNA mutations and oxidative damage in aging and diseases: An emerging paradigm of gerontology and medicine. Proc Natl Sci Counc Repub China B 1998;22:55-67.
12. Fisher GJ, Talwar HS, Lin J, Lin P, McPhillips F, Wang Z, Li X, Wan Y, Kang S, Voorhees JJ: Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 1998;101:1432-1440.
13. Salasche SJ: Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000;42:4-7.
14. Engel A, Johnson ML, Haynes SG: Health effects of sunlight exposure in the United States. Results from the first National Health and Nutrition Examination Survey, 1971-1974. Arch Dermatol 1988;124:72-79.
15. Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M: Non-melanoma skin cancer and solar keratoses. 1. Methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer 1996;74:1302-1307.
16. Moy RL: Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000;42:8-10.
17. Cohn BA: From sunlight to actinic keratosis to squamous cell carcinoma. J Am Acad Dermatol 2000;42:143-144.
18. Cockerell CJ: Histopathology of incipient intraepidermal squamous cell carcinoma ('actinic keratosis'). J Am Acad Dermatol 2000;42:11-17.
19. Dinehart SM, Nelson-Adesokan P, Cockerell C, Russell S, Brown R: Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 1997;79:920-923.
20. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ: Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1996;1:136-142.
21. Schwartz RA: The actinic keratosis. A perspective and update. Dermatol Surg 1997;23:1009-1019.
22. Leffell DJ: The scientific basis of skin cancer. J Am Acad Dermatol 2000;42:18-22.
23. Einspahr J, Alberts DS, Aickin M, Welch K, Bozzo P, Grogan T, Nelson M: Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin. Cancer Epidemiol Biomarkers Prev 1997;6:583-587.
24. Hurwitz RM, Monger LE: Solar keratosis: An evolving squamous cell carcinoma. Benign or malignant? Dermatol Surg 1995;21:184.
25. Mortier L, Marchetti P, Delaporte E, Martin de Lassalle E, Thomas P, Piette F, Formstecher P, Polakowska R, Danze PM: Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor. Cancer Lett 2002;176:205-214.
26. Filipowicz E, Adegboyega P, Sanchez RL, Gatalica Z: Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas. Cancer 2002;94:814-819.
27. Korabiowska M, Berger H, Keci A, Nagel H, Ruschenburg I, Droese M, Brinck U: Comparison of the DNA content in the different steps of cutaneous carcinoma progression. In Vivo 1999;13:553-557.
28. Jin Y, Jin C, Salemark L, Wennerberg J, Persson B, Jonsson N: Clonal chromosome abnormalities in premalignant lesions of the skin. Cancer Genet Cytogenet 2002;136:48-52.
29. Miller DL, Weinstock MA: Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 1994;30:774-778.
30. Glogau RG: The risk of progression to invasive disease. J Am Acad Dermatol 2000;42:23-24.
31. Yantsos VA, Conrad N, Zabawski E, Cockerell CJ: Incipient intraepidermal cutaneous squamous cell carcinoma: A proposal for reclassifying and grading solar (actinic) keratoses. Semin Cutan Med Surg 1999;18:3-14.
32. Lober BA, Lober CW: Actinic keratosis is squamous cell carcinoma. South Med J 2000;93:650-655.
33. Dubreuilh WA: Des hyperkératoses circonscrites. Ann Dermatol Vénéréol 1896;27:1158-1202.
34. Sutton RLJ: Early epidermal neoplasia: Description and interpretation - The theory of mutation in the origin of cancer. Arch Derm Syphilol 1938;37:737-780.
35. Panjehpour M, Julius CE, Phan MN, Vo-Dinh T, Overholt S: Laser-induced fluorescence spectroscopy for in vivo diagnosis of non-melanoma skin cancers. Lasers Surg Med 2002;31:367-373.
36. Fritsch C, Goerz G, Ruzicka T: Photodynamic therapy in dermatology. Arch Dermatol 1998;134:207-214.
37. Szeimies RM, Landthaler M: Photodynamic therapy and fluorescence diagnosis of skin cancers. Recent Results Cancer Res 2002;160:240-245.
38. Aghassi D, Anderson RR, Gonzalez S: Confocal laser microscopic imaging of actinic keratoses in vivo: A preliminary report. J Am Acad Dermatol 2000;43:42-48.
39. Tanaka K, Sekiguchi M, Okada Y: Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus). Proc Natl Acad Sci USA 1975;72:4071-4075.
40. Yarosh D, Klein J, Kibitel J, Alas L, O'Connor A, Cummings B, Grob D, Gerstein D, Gilchrest BA, Ichihashi M, Ogoshi M, Ueda M, Fernandez V, Chadwick C, Potten CS, Proby CM, Young AR, Hawk JL: Enzyme therapy of xeroderma pigmentosum: Safety and efficacy testing of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme. Photodermatol Photoimmunol Photomed 1996;12:122-130.
41. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P: Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: A randomised study. Xeroderma Pigmentosum Study Group. Lancet 2001;357:926-929.
42. Stege H, Roza L, Vink AA, Grewe M, Ruzicka T, Grether-Beck S, Krutmann J: Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci USA 2000;97:1790-1795.
43. Krutmann J: New developments in photoprotection of human skin. Skin Pharmacol Appl Skin Physiol 2001;14:401-407.
44. Rattan SI, Clark BF: Kinetin delays the onset of ageing characteristics in human fibroblasts. Biochem Biophys Res Commun 1994;201:665-672.
45. Weinstein GD, McCullough JL, Ali NN, Shull TF, Moudy D: A double-blind vehicle-controlled study of kinetin lotions for improving the appearance of aging photodamaged facial skin with 24 weeks of twice daily topical application. IBC Conf Photoaging latest adv understand treat prev, Short Hills, 1997.
46. Ditre CM, Griffin TD, Murphy GF, Sueki H, Telegan B, Johnson WC, Yu RJ, Van Scott EJ: Effects of alpha-hydroxy acids on photoaged skin: A pilot clinical, histologic, and ultrastructural study. J Am Acad Dermatol 1996;34:187-195.
47. Kligman AM, Grove GL, Hirose R, Leyden JJ: Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986;15:836-859.
48. Weiss JS, Ellis CN, Headington JT, Voorhees JJ: Topical tretinoin in the treatment of aging skin. J Am Acad Dermatol 1988;19:169-175.
49. Monheit GD: Consultation for photoaging skin. Dermatol Clin 2001;19:401-403, vii.
50. Glogau RG, Matarasso SL: Chemical peels. Trichloroacetic acid and phenol. Dermatol Clin 1995;13:263-276.
51. Appa Y: Retinoid therapy: Compatible skin care. Skin Pharmacol Appl Skin Physiol 1999;12:111-119.
52. Darr D, Dunston S, Faust H, Pinnell S: Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants. Acta Derm Venereol 1996;76:264-268.
53. Fitzpatrick RE, Rostan EF: Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg 2002;28:231-236.
54. Winton GB, Salasche SJ: Dermabrasion of the scalp as a treatment for actinic damage. J Am Acad Dermatol 1986;14:661-668.
55. Lowe NJ, Lask G, Griffin ME, Maxwell A, Lowe P, Quilada F: Skin resurfacing with the Ultrapulse carbon dioxide laser. Observations on 100 patients. Dermatol Surg 1995;21:1025-1029.
56. Fitzpatrick RE, Goldman MP, Satur NM, Tope WD: Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch Dermatol 1996;132:395-402.
57. 2/erbium:YAG laser resurfacing of peri-oral rhytides and side-by-side comparison with carbon dioxide laser alone. Dermatol Surg 1999;25:285-293.
58. 2 laser. Lasers Surg Med 2001;29:136-141.
59. Bernstein EF, Andersen D, Zelickson BD: Laser resurfacing for dermal photoaging. Clin Plast Surg 2000;27:221-240.
60. Goldberg DJ: Non-ablative subsurface remodeling: Clinical and histologic evaluation of a 1320-nm Nd:YAG laser. J Cutan Laser Ther 1999;1:153-157.
61. Menaker GM, Wrone DA, Williams RM, Moy RL: Treatment of facial rhytids with a nonablative laser: A clinical and histologic study. Dermatol Surg 1999;25:440-444.
62. Zelickson BD, Kilmer SL, Bernstein E, Chotzen VA, Dock J, Mehregan D, Coles C: Pulsed dye laser therapy for sun-damaged skin. Lasers Surg Med 1999;25:229-236.
63. Goldman MP: Treatment of benign vascular lesions with the Photoderm VL high-intensity pulsed light source. Adv Dermatol 1997;13:503-521.
64. Bitter PH: Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000;26:835-842.
65. Dinehart SM: The treatment of actinic keratoses. J Am Acad Dermatol 2000;42:25-28.
66. Jeffes EW 3rd, Tang EH: Actinic keratosis. Current treatment options. Am J Clin Dermatol 2000;1:167-179.
67. Loven K, Stein L, Furst K, Levy S: Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther 2002;24:990-1000.
68. Levy S, Furst K, Chern W: A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation. Clin Ther 2001;23:901-907.
69. Rivers JK, McLean DI: An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. Arch Dermatol 1997;133:1239-1242.
70. Wolf JE Jr, Taylor JR, Tschen E, Kang S: Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001;40:709-713.
71. Peters DC, Foster RH: Diclofenac/hyaluronic acid. Drugs Aging 1999;14:313-319.
72. Brown MB, Hanpanitcharoen M, Martin GP: An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs. Int J Pharm 2001;225:113-121.
73. Moore AR, Willoughby DA: Hyaluronan as a drug delivery system for diclofenac: A hypothesis for mode of action. Int J Tissue React 1995;17:153-156.
74. Marnett LJ: Generation of mutagens during arachidonic acid metabolism. Cancer Metastasis Rev 1994;13:303-308.
75. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000;60:1306-1311.
76. An KP, Athar M, Tang X, Katiyar SK, Russo J, Beech J, Aszterbaum M, Kopelovich L, Epstein EH Jr, Mukhtar H, Bickers DR: Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: Implications for therapeutic approaches. Photochem Photobiol 2002;76:73-80.
77. Stockfleth E, Meyer T, Benninghoff B, Christophers E: Successful treatment of actinic keratosis with imiquimod cream 5%: A report of six cases. Br J Dermatol 2001;144:1050-1053.
78. Stockfleth E, Meyer T, Benninghoff B, Salasche S, Papadopoulos L, Ulrich C, Christophers E: A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002;138:1498-1502.
79. Marshall J: Treatment of solar keratoses with topically applied cytostatic agents. Br J Dermatol 1968;80:540-542.
80. Grimaitre M, Etienne A, Fathi M, Piletta PA, Saurat JH: Topical colchicine therapy for actinic keratoses. Dermatology 2000;200:346-348.
81. Akar A, Bulent Tastan H, Erbil H, Arca E, Kurumlu Z, Gur AR: Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses. J Dermatolog Treat 2001;12:199-203.
82. Kennedy JC, Pottier RH: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992;14:275-292.
83. Wolf P, Rieger E, Kerl H: Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol 1993;28:17-21.
84. Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JS, Shull TF, Simpson KR, Bukaty LM, Hoffman WL, Fong NL: Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol 1997;133:727-732.
85. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, Sidoroff A, Hempel M, Ulrich J, Proebstle T, Meffert H, Mulder M, Salomon D, Dittmar HC, Bauer JW, Kernland K, Braathen L: Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 2002;47:258-262.
86. Gardlo K, Ruzicka T: Metvix (PhotoCure). Curr Opin Investig Drugs 2002;3:1672-1678.
87. Dijkstra AT, Majoie IM, van Dongen JW, van Weelden H, van Vloten WA: Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J Eur Acad Dermatol Venereol 2001;15:550-554.
88. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S: Photodynamic photorejuvenation. Dermatol Surg 2002;28:742-744.
89. Callen JP: Panel discussion and concluding remarks. J Am Acad Dermatol 2000;42:29-30.
90. Moloney FJ, Collins S, Murphy GM: Sunscreens: Safety, efficacy and appropriate use. Am J Clin Dermatol 2002;3:185-191.
91. Boyd AS, Stasko T, King LE Jr, Cameron GS, Pearse AD, Gaskell SA: Cigarette smokingassociated elastotic changes in the skin. J Am Acad Dermatol 1999;41:23-26.